PDF herunterladen
Horm Metab Res 2022; 54(11): 768-779
DOI: 10.1055/a-1926-7280
Original Article: Endocrine Research

Knockdown of Endogenous Nucb2/Nesfatin-1 in the PVN Leads to Obese-Like Phenotype and Abolishes the Metformin- and Stress-Induced Thermogenic Response in Rats

Daniel Stephan   *
1   Department of Internal Medicine I, University of Lübeck, Lübeck, Germany
2   Department of Oral- and Maxillofacial Surgery, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
3   Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Lübeck, Germany
,
Natalie Taege    *
1   Department of Internal Medicine I, University of Lübeck, Lübeck, Germany
4   Institute of Human Genetics, Section Epigenetics & Metabolism, University of Lübeck, Lübeck, Germany
,
Riccardo Dore
1   Department of Internal Medicine I, University of Lübeck, Lübeck, Germany
5   Institute of Endocrinology and Diabetes, University of Lübeck, Lübeck, Germany
3   Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Lübeck, Germany
,
Julica Folberth
6   Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany
3   Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Lübeck, Germany
,
Olaf Jöhren
3   Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Lübeck, Germany
,
Markus Schwaninger 
6   Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany
,
Hendrik Lehnert
1   Department of Internal Medicine I, University of Lübeck, Lübeck, Germany
7   Rektorat, Paris Lodron Universität Salzburg, Salzburg, Austria
,
Carla Schulz
1   Department of Internal Medicine I, University of Lübeck, Lübeck, Germany
3   Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Lübeck, Germany
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Nesfatin-1, the cleavage product of nucleobindin-2, is an anorexigenic peptide and major regulator of energy homeostasis. Beyond reducing food intake and increasing energy expenditure, it is also involved in regulating the stress response. Interaction of nucleobindin-2/nesfatin-1 and glucose homeostasis has been observed and recent findings suggest a link between the action of the antidiabetic drug metformin and the nesfatinergic system. Hence, this study aimed to clarify the role of nucleobindin-2/nesfatin-1 in the paraventricular nucleus of the hypothalamus in energy homeostasis as well as its involvement in stress- and metformin-mediated changes in energy expenditure. Knockdown of nucleobindin-2/nesfatin-1 in male Wistar rats led to significantly increased food intake, body weight, and reduced energy expenditure compared to controls. Nucleobindin-2/nesfatin-1 knockdown animals developed an obese-like phenotype represented by significantly increased fat mass and overall increase of circulating lipids. Concomitantly, expression of nucleobindin-2 and melanocortin receptor type 3 and 4 mRNA in the paraventricular nucleus was decreased indicating successful knockdown and impairment at the level of the melanocortin system. Additionally, stress induced activation of interscapular brown adipose tissue was significantly decreased in nucleobindin-2/nesfatin-1 knockdown animals and accompanied by lower adrenal weight. Finally, intracerebroventricular administration of metformin significantly increased energy expenditure in controls and this effect was absent in nucleobindin-2/nesfatin-1 knockdown animals. Overall, we clarified the crucial role of nucleobindin-2/nesfatin-1 in the paraventricular nucleus of the hypothalamus in the regulation of energy homeostasis. The nesfatinergic system was further identified as important mediator in stress- and metformin-induced thermogenesis.

Key words

energy homeostasis - obesity  - metabolic syndrome - oral antidiabetic drugs; OAD  - diabetes - hypothalamus - NTS - brown adipose tissue

* These authors contributed equally.


Supplementary Material



Publikationsverlauf

Eingereicht: 11. Mai 2022

Angenommen nach Revision: 11. August 2022

Artikel online veröffentlicht:
04. Oktober 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Oh-I S, Shimizu H, Satoh T. et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006; 443: 709-712
    CrossrefPubMedGoogle Scholar
  • 2 Wernecke K, Lamprecht I, Jöhren O. et al. Nesfatin-1 increases energy expenditure and reduces food intake in rats. Obesity 2014; 22: 1662-1668
    CrossrefPubMedGoogle Scholar
  • 3 Dore R, Levata L, Lehnert H. et al. Nesfatin-1: functions and physiology of a novel regulatory peptide. J Endocrinol 2017; 232: R45-R65
    CrossrefPubMedGoogle Scholar
  • 4 Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004; 84: 277-359
    CrossrefPubMedGoogle Scholar
  • 5 Dore R, Levata L, Gachkar S. et al. The thermogenic effect of nesfatin-1 requires recruitment of the melanocortin system. J Endocrinol 2017; 235: 111-122
    CrossrefPubMedGoogle Scholar
  • 6 Foo KS, Brismar H, Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience 2008; 156: 563-579
    CrossrefPubMedGoogle Scholar
  • 7 Kohno D, Nakata M, Maejima Y. et al. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 2008; 149: 1295-1301
    CrossrefPubMedGoogle Scholar
  • 8 Ramanjaneya M, Chen J, Brown JE. et al. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 2010; 151: 3169-3180
    CrossrefPubMedGoogle Scholar
  • 9 Stengel A, Goebel M, Yakubov I. et al. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 2009; 150: 232-238
    CrossrefPubMedGoogle Scholar
  • 10 Brailoiu GC, Dun SL, Brailoiu E. et al. Nesfatin-1: Distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 2007; 148: 5088-5094
    CrossrefPubMedGoogle Scholar
  • 11 Rupp SK, Wölk E, Stengel A. Nesfatin-1 receptor: distribution, signaling and increasing evidence for a G protein-coupled receptor – a systematic review. Front Endocrinol (Lausanne) 2021; 12: 740174
    CrossrefPubMedGoogle Scholar
  • 12 Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428
    CrossrefPubMedGoogle Scholar
  • 13 Liu Y, Chen X, Qu Y. et al. Central nesfatin-1 activates lipid mobilization in adipose tissue and fatty acid oxidation in muscle via the sympathetic nervous system. Biofactors 2020; 46: 454-464
    CrossrefPubMedGoogle Scholar
  • 14 Chen X, Dong J, Jiang Z-Y. Nesfatin-1 influences the excitability of glucosensing neurons in the hypothalamic nuclei and inhibits the food intake. Regul Pept 2012; 177: 21-26
    CrossrefPubMedGoogle Scholar
  • 15 Wu D, Yang M, Chen Y. et al. Hypothalamic nesfatin-1/NUCB2 knockdown augments hepatic gluconeogenesis that is correlated with inhibition of mTOR-STAT3 signaling pathway in rats. Diabetes 2014; 63: 1234-1247
    CrossrefPubMedGoogle Scholar
  • 16 Yang M, Zhang Z, Wang C. et al. Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance. Diabetes 2012; 61: 1959-1968
    CrossrefPubMedGoogle Scholar
  • 17 Su Y, Zhang J, Tang Y. et al. The novel function of nesfatin-1: anti-hyperglycemia. Biochem Biophys Res Commun 2010; 391: 1039-1042
    CrossrefPubMedGoogle Scholar
  • 18 Zhou G, Myers R, Li Y. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167-1174
    CrossrefPubMedGoogle Scholar
  • 19 Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000; 348: 607-614
    CrossrefPubMedGoogle Scholar
  • 20 Lee CK, Choi YJ, Park SY. et al. Intracerebroventricular injection of metformin induces anorexia in rats. Diabetes Metab J 2012; 36: 293-299
    CrossrefPubMedGoogle Scholar
  • 21 Tokubuchi I, Tajiri Y, Iwata S. et al. Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats. PLoS One 2017; 12: e0171293
    CrossrefPubMedGoogle Scholar
  • 22 Rouquet T, Clément P, Gaigé S. et al. Acute oral metformin enhances satiation and activates brainstem nesfatinergic neurons. Obesity 2014; 22: 2552-2562
    PubMedGoogle Scholar
  • 23 Merali Z, Cayer C, Kent P. et al. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology 2008; 201: 115
    CrossrefPubMedGoogle Scholar
  • 24 Könczöl K, Bodnár I, Zelena D. et al. Nesfatin-1/NUCB2 may participate in the activation of the hypothalamic–pituitary–adrenal axis in rats. Neurochem Int 2010; 57: 189-197
    CrossrefPubMedGoogle Scholar
  • 25 Goebel M, Stengel A, Wang L. et al. Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats. Brain Res 2009; 1300: 114-124
    CrossrefPubMedGoogle Scholar
  • 26 Yoshida N, Maejima Y, Sedbazar U. et al. Stressor-responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary-adrenal axis. Aging (Albany NY) 2010; 2: 775-784
    CrossrefPubMedGoogle Scholar
  • 27 Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sixth Edition. Elsevier: Academic Press; New York: 2006
    Google Scholar
  • 28 Dore R, Iemolo A, Smith KL. et al. CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP. Neuropsychopharmacology 2013; 38: 2160-2169
    CrossrefPubMedGoogle Scholar
  • 29 Aherrahrou R, Kulle AE, Alenina N. et al. CYP17A1 deficient XY mice display susceptibility to atherosclerosis, altered lipidomic profile and atypical sex development. Sci Rep 2020; 10: 8792
    CrossrefPubMedGoogle Scholar
  • 30 Karsai G, Kraft F, Haag N. et al. DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans. J Clin Invest 2019; 129: 1229-1239
    CrossrefPubMedGoogle Scholar
  • 31 Schulz C, Paulus K, Jöhren O. et al. Intranasal leptin reduces appetite and induces weight loss in rats with diet-induced obesity (DIO). Endocrinology 2012; 153: 143-153
    CrossrefPubMedGoogle Scholar
  • 32 Chong J, Soufan O, Li C. et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 2018; 46: W486-W494
    CrossrefPubMedGoogle Scholar
  • 33 Pang Z, Chong J, Zhou G. et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res 2021; 49: W388-W396
    CrossrefPubMedGoogle Scholar
  • 34 Darambazar G, Nakata M, Okada T. et al. Paraventricular NUCB2/nesfatin-1 is directly targeted by leptin and mediates its anorexigenic effect. Biochem Biophys Res Commun 2015; 456: 913-918
    CrossrefPubMedGoogle Scholar
  • 35 Maejima Y, Sedbazar U, Suyama S. et al. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab 2009; 10: 355-365
    CrossrefPubMedGoogle Scholar
  • 36 Dore R, Krotenko R, Reising JP. et al. Nesfatin-1 decreases the motivational and rewarding value of food. Neuropsychopharmacology 2020; 45: 1645-1655
    CrossrefPubMedGoogle Scholar
  • 37 Wilz A-M, Wernecke K, Appel L. et al. Endogenous NUCB2/nesfatin-1 regulates energy homeostasis under physiological conditions in male rats. Horm Metab Res 2020; 52: 676-684
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 38 Nakata M, Gantulga D, Santoso P. et al. Paraventricular NUCB2/nesfatin-1 supports oxytocin and vasopressin neurons to control feeding behavior and fluid balance in male mice. Endocrinology 2016; 157: 2322-2332
    CrossrefPubMedGoogle Scholar
  • 39 Levata L, Dore R, Jöhren O. et al. Nesfatin-1 acts centrally to induce sympathetic activation of brown adipose tissue and non-shivering thermogenesis. Horm Metab Res 2019; 51: 678-685
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 40 Aksu O, Aydın B, Doguç DK. et al. The evaluation of nesfatin-1 levels in patients with OSAS associated with metabolic syndrome. J Endocrinol Invest 2015; 38: 463-469
    CrossrefPubMedGoogle Scholar
  • 41 Gonzalez R, Perry RLS, Gao X. et al. Nutrient responsive nesfatin-1 regulates energy balance and induces glucose-stimulated insulin secretion in rats. Endocrinology 2011; 152: 3628-3637
    CrossrefPubMedGoogle Scholar
  • 42 Dong J, Xu H, Xu H. et al. Nesfatin-1 stimulates fatty-acid oxidation by activating AMP-activated protein kinase in STZ-induced type 2 diabetic mice. PLoS One 2013; 8: e83397
    CrossrefPubMedGoogle Scholar
  • 43 Grösch S, Schiffmann S, Geisslinger G. Chain length-specific properties of ceramides. Prog Lipid Res 2012; 51: 50-62
    CrossrefPubMedGoogle Scholar
  • 44 Gonzalez R, Reingold BK, Gao X. et al. Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet □- and MIN6 cells. J Endocrinol 2011; 208: R9-R16
    PubMedGoogle Scholar
  • 45 Li Z, Gao L, Tang H. et al. Peripheral effects of nesfatin-1 on glucose homeostasis. PLoS One 2013; 8: e71513
    CrossrefPubMedGoogle Scholar
  • 46 Blevins JE, Baskin DG. Hypothalamic-brainstem circuits controlling eating. Forum Nutr 2010; 63: 133-140
    CrossrefPubMedGoogle Scholar
  • 47 Larsen PJ, Hay-Schmidt A, Mikkelsen JD. Efferent connections from the lateral hypothalamic region and the lateral preoptic area to the hypothalamic paraventricular nucleus of the rat. J Comp Neurol 1994; 342: 299-319
    CrossrefPubMedGoogle Scholar
  • 48 Bamshad M, Song CK, Bartness TJ. CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am J Physiol 1999; 276: R1569-R1578
    PubMedGoogle Scholar
  • 49 Bamshad M, Aoki VT, Adkison MG. et al. Central nervous system origins of the sympathetic nervous system outflow to white adipose tissue. Am J Physiol 1998; 275: R291-R299
    PubMedGoogle Scholar
  • 50 Shi Y-C, Lau J, Lin Z. et al. Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Cell Metab 2013; 17: 236-248
    CrossrefPubMedGoogle Scholar
  • 51 Xu Y-Y, Ge J-F, Qin G. et al. Acute, but not chronic, stress increased the plasma concentration and hypothalamic mRNA expression of NUCB2/nesfatin-1 in rats. Neuropeptides 2015; 54: 47-53
    CrossrefPubMedGoogle Scholar
  • 52 Ulrich-Lai YM, Figueiredo HF, Ostrander MM. et al. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am J PhysiolEndocrinol Metab 2006; 291: E965-E973
    CrossrefPubMedGoogle Scholar